Company | Live Nation Entertainment, Inc. |
Ticker | LYV (NYSE) |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Date | July 30, 2026 (after market close) |
Last Earnings Date | May 5, 2026 (Q1 2026) |
Prepared | July 29, 2026 |
Primary Valuation Metric | EV/EBITDA (NTM: ~20.1x) |
Key Takeaway: The setup into Q2 2026 is constructive — consensus is a manageable bar with the real story being the strength of the full-year pipeline — but the single biggest swing factor is whether amphitheater on-site per-cap spending holds up through the peak summer season.
Heading into Q2 2026, Live Nation's bar looks achievable: consensus calls for revenue of ~$7.56B (+8% YoY) and EBITDA of ~$652M (+1% YoY vs. a tough Q2 2025 comp), with diluted EPS of ~$0.62 — a meaningful step-up from the prior-year $0.41. Management's tone has been unambiguously confident since the Q1 print, with CFO Berchtold citing 119 million tickets sold through late May (up double-digits YoY), record event-related deferred revenue of $6.6B (+22%), and sell-through rates across stadiums, arenas, and amphitheaters all tracking in line with or ahead of last year. Estimate revisions have been remarkably stable post-Q1 — revenue and EBITDA consensus for Q2 have barely moved since the May 8 baseline, suggesting the street is comfortable with the guide rather than chasing upside. The stock has re-rated sharply since the Q1 print (+17% vs. flat SPY), recovering most of the April antitrust-verdict selloff, which means the market has already priced in a solid operational quarter and the legal overhang is now a known risk rather than a surprise. The key wildcard is amphitheater per-cap spending: with ~70% of amphitheater fan growth concentrated in Q3, Q2 is primarily an arena/third-party venue quarter, but early amphitheater data (only ~5% of shows played off as of late May) showed on-site spending up with no trade-down — any deterioration in that trend through June would be the most likely negative surprise.
Key Takeaway: Consensus is a moderate bar on revenue (+8% YoY) but a tighter bar on EBITDA (+1% YoY vs. a strong Q2 2025 comp); the bigger swing factor is total fans and fee-bearing ticket volume, which will signal whether the record deferred revenue is converting into actual attendance.
KPI | Q1 2026 Actual (Last Qtr) | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | FY2026 Guidance | Consensus vs. Guidance |
Total Revenue ($B) | $3.79B | $7.01B | $7.56B | +7.9% | Double-digit AOI growth; high-single-digit fan growth | N/A (no explicit Q2 revenue guide) |
EBITDA ($M) | -$201M (incl. $450M legal accrual) | $646M | $652M | +1.0% | Double-digit AOI growth FY2026 | N/A (no explicit Q2 EBITDA guide) |
Diluted EPS ($) | -$1.85 (incl. $1.93 legal charge) | $0.41 | $0.62 | +52% | No explicit EPS guide | N/A |
Total Fans (K) | 23,788K | 44,215K | 46,778K | +5.8% | High-single-digit FY growth; Q2 led by third-party arenas | In line with guide |
Total Events (#) | 11,396 | 14,292 | 14,893 | +4.2% | Show counts up YoY across all venue types | In line with guide |
Fee-Bearing Tickets Sold (M) | 80.6M | 83.3M | 84.7M | +1.7% | Mid-single-digit primary volume growth FY2026 | In line with guide |
Ticketing GTV ($B) | $8.92B | $9.06B | $9.68B | +6.8% | GTV growth driven by concert volume + pricing | N/A (no explicit GTV guide) |
Ticketing Revenue ($M) | $765M | $743M | $769M | +3.5% | Mid-single-digit primary volume growth; secondary headwind mid-single-digit drag to AOI | Slight premium to guide (secondary headwind partially offset by volume) |
Sponsorship & Advertising Revenue ($M) | $259M | $341M | $383M | +12.3% | Double-digit AOI growth FY2026 | In line with guide |
Source: Visible Alpha Consensus and Actuals Data; LYV Q1 2026 Earnings Release (May 5, 2026). All consensus figures as of July 29, 2026.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Total Revenue | $3.79B | $3.57B | +6.1% | Beat |
Q1 2026 | Total Fans | 23,788K | 22,923K | +3.8% | Beat |
Q4 2025 | Total Revenue | $6.31B | $6.10B | +3.5% | Beat |
Q4 2025 | Total Fans | 41,375K | 41,766K | -1.0% | Miss |
Q3 2025 | Total Revenue | $8.50B | $8.57B | -0.9% | Miss |
Q3 2025 | Total Fans | 51,269K | 51,946K | -1.3% | Miss |
Q2 2025 | Total Revenue | $7.01B | $6.78B | +3.4% | Beat |
Q2 2025 | Total Fans | 44,215K | 42,944K | +3.0% | Beat |
Q1 2025 | Total Revenue | $3.38B | $3.48B | -2.8% | Miss |
Q1 2025 | Total Fans | 22,307K | 22,204K | +0.5% | Beat |
Q4 2024 | Total Revenue | $5.68B | $5.60B | +1.4% | Beat |
Q4 2024 | Total Fans | 39,123K | 36,080K | +8.4% | Beat |
Q3 2024 | Total Revenue | $7.65B | $7.81B | -2.0% | Miss |
Q3 2024 | Total Fans | 50,104K | 52,484K | -4.5% | Miss |
Source: Visible Alpha Consensus and Actuals Data. LYV has a mixed beat/miss pattern on revenue (5 beats, 3 misses in 8 quarters) and fans (5 beats, 3 misses), with misses concentrated in peak-season quarters (Q3 2024, Q3 2025) where the bar was set high — suggesting consensus tends to overshoot in the seasonally heavy quarters.
Key Takeaway: Guidance has been unchanged since the Q1 2026 earnings call — management reiterated double-digit AOI growth for the full year at two subsequent investor conferences — but tone has shifted more defensive on the demand narrative (explicitly rebutting ‘blue dot fever’ cancellation concerns) while remaining operationally confident.
Metric | Initial Guidance (Q1 2026 Earnings — May 5, 2026) | Revised Guidance | Current Consensus | Note |
FY2026 AOI Growth | Double-digit growth | — | EBITDA $1.78B (FY2026 cons.) | Reiterated at Moffett Nathanson (May 14) and JP Morgan TMC (May 20) conferences; tone confident |
Concerts: FY Fan Attendance | High-single-digit growth | — | 171M fans (FY2026 cons.) | Unchanged; Q2 growth led by third-party arenas; 70% of amphitheater growth in Q3 |
Concerts: FY AOI Growth | Double-digit growth; margins to build on 2025 | — | In line with guide | Unchanged; stadium/amphitheater show counts up YoY; all stadium growth in H2 |
Ticketmaster: Primary Fee-Bearing Volume | Mid-single-digit growth FY2026 | — | 84.7M tickets Q2 cons.; 355M FY cons. | Unchanged; secondary headwind (mid-single-digit drag to Ticketmaster AOI) is one-time structural step-down |
Ticketmaster: FY AOI Margin | Similar to 2025 | — | In line with guide | Unchanged; legal/operational expenses to moderate over next few quarters |
Sponsorship & Advertising: FY AOI | Double-digit growth; margin similar to 2025 | — | $383M Q2 cons.; $1.51B FY cons. | Unchanged; driven by venue portfolio expansion, naming rights, international festivals |
FY2026 CapEx | $1.1–$1.2B total; ~$800–$850M for venue expansion | — | N/A | Unchanged; ~$250M offset from JV partners/sponsorship; venue securitization (EUR 610M) closed May 8, 2026 |
Net Interest Expense (FY2026) | $280M | — | N/A | Unchanged |
AOI Phasing | Q3 strongest (stadium/amphitheater calendar); Q4 also strong; Q2 led by third-party arenas | — | Consistent with guide | Reiterated at both May conferences; no change to phasing expectations |
Source: LYV Q1 2026 Earnings Call Transcript (May 5, 2026); Moffett Nathanson Conference Transcript (May 14, 2026); JP Morgan TMC Conference Transcript (May 20, 2026); Visible Alpha Consensus.
Key Takeaway: Estimates have been remarkably stable since the Q1 print — Q2 revenue consensus has moved less than 0.1% and EBITDA less than 1% since the May 8 baseline — suggesting the street is comfortable with management’s guide rather than building in upside; the gap between consensus and guidance is not a risk or a cushion, it’s a neutral read.
KPI (Period) | Estimate (May 8, 2026 — 5 Days Post Q1 Print) | Current Consensus (Jul 29, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Total Revenue — Q2 2026 | $7.557B | $7.553B | -0.05% | No explicit Q2 guide | No explicit Q2 guide | — | N/A |
Total Revenue — FY2026 | $27.776B | $27.792B | +0.06% | High-single-digit fan growth; double-digit AOI growth | Unchanged | — | N/A (no explicit revenue guide) |
EBITDA — Q2 2026 | $647.5M | $652.1M | +0.7% | No explicit Q2 guide | No explicit Q2 guide | — | N/A |
EBITDA — FY2026 | $1.752B | $1.781B | +1.7% | Double-digit AOI growth | Unchanged | — | Consensus implies ~15–20% AOI growth, consistent with guide |
Diluted EPS — Q2 2026 | $0.606 | $0.624 | +3.0% | No explicit EPS guide | No explicit EPS guide | — | N/A |
Diluted EPS — FY2026 | -$0.279 | -$0.164 | +41% (less negative) | No explicit EPS guide; $450M legal accrual impacts FY GAAP | Unchanged | — | FY EPS improving as legal charge is absorbed; GAAP EPS remains negative FY2026 |
Source: Visible Alpha Consensus and Actuals Data (revision history weekly series, May 8 – July 29, 2026). Estimates have been essentially flat since the Q1 print across all key metrics, confirming the street is anchored to management’s guide. The modest upward drift in FY EBITDA (+1.7%) and Q2 EPS (+3.0%) suggests slight positive revision bias, but not enough to call it a meaningful setup for a beat.
Key Takeaway: LYV has significantly outperformed both the consumer discretionary/leisure ETF (PEJ) and the S&P 500 since the Q1 print, driven almost entirely by multiple re-expansion (EV/EBITDA expanded from ~17.6x to ~20.1x over 3 months) as the antitrust overhang was partially de-risked by the DOJ settlement and the legal process timeline became clearer.
Since the Q1 2026 earnings release on May 5, 2026, LYV has returned approximately +17.3% (from $157.26 to $184.43 as of July 30, 2026), compared to +12.3% for PEJ (Invesco Dynamic Leisure & Entertainment ETF) and +0.8% for the S&P 500 (SPY). The outperformance is notable given the stock had already sold off sharply in April following the state AG jury verdict. The re-rating has been driven by multiple expansion rather than estimate revisions (which have been flat), suggesting the market is pricing in legal risk reduction and confidence in the 2026 pipeline. PEJ is used as the sector proxy given LYV’s primary exposure to live entertainment and leisure consumer spending.
Milestone | Date | LYV Price | Event |
Q1 2026 Earnings (Base) | May 5, 2026 | $157.26 | Q1 2026 results; revenue beat; $450M legal accrual; record deferred revenue |
Venue Securitization Close | May 8, 2026 | $163.28 | EUR 610M senior secured notes offering closed; Venue Nation financing confirmed |
Moffett Nathanson Conference | May 14, 2026 | $169.99 | CFO Berchtold reiterates demand strength; 'blue dot fever' rebuttal; sell-through rates in line with prior year |
JP Morgan TMC Conference | May 20, 2026 | $164.44 | 119M tickets sold (up from 107M at Q1); per-cap spending up at early amphitheater shows |
Annual Shareholder Meeting | Jun 12, 2026 | $172.51 | All proposals approved; stock continues re-rating |
Q2 2026 Earnings Date Announced | Jul 16, 2026 | $179.85 | Earnings scheduled for July 30, 2026 after market close |
As of Preparation Date | Jul 29, 2026 | $184.43 | LYV +17.3% vs. PEJ +12.3% vs. SPY +0.8% since May 5 |
Source: Stock Price Data (Yahoo Finance). Indexed to 100 at May 5, 2026 close. PEJ = Invesco Dynamic Leisure & Entertainment ETF (selected as sector proxy for live entertainment/leisure consumer discretionary).
Key Takeaway: The most important development since Q1 earnings is the closure of the EUR 610M venue securitization, which de-risks the Venue Nation capex program and confirms the financing structure; the antitrust legal process timeline has also become clearer, reducing near-term uncertainty even as the remedies phase remains a multi-year overhang.
Key Takeaway: The most relevant peer read-through for LYV’s Q2 2026 print comes from CTS Eventim’s 2026 European festival season commentary (July 2026), which corroborates LYV management’s demand narrative with independent evidence of strong live event attendance in Europe. Note: TKO Group (ticker TKO FP in the database) reported Q2 2026 on July 29, 2026, but is a European alternative asset manager — not the US sports/entertainment TKO — and provides no read-through to LYV.
Methodology Note: Only commentary released within the last 60 days (on or after May 29, 2026) that speaks to the contemporaneous 2026 reporting period or forward outlook is included below. Retrospective prior-quarter-only commentary has been explicitly excluded.
Relevance: CTS Eventim is Europe’s largest ticketing and live entertainment company and LYV’s closest structural peer outside the US. Its commentary on the 2026 European festival season is a direct read-through to LYV’s international concerts and Ticketmaster segments. Caveat: This is a narrow, non-US read-through; CTS Eventim is not US-listed and operates primarily in European markets. LYV’s international business is growing rapidly but still represents a minority of total revenue.
Note: The following is LYV management’s own forward-looking commentary from investor conferences held after the Q1 2026 earnings call. While not a ‘peer’ read-through, it is included here as the most relevant contemporaneous commentary on Q2 2026 and the 2026 season outlook.
Key Takeaway: Insider activity since the Q1 print is dominated by routine tax-withholding disposals (Form 4 code ‘F’) and option exercises — no open-market discretionary buys or sells stand out. The June 11 cluster of director stock awards (code ‘A’) is standard annual compensation. No unusual insider selling or buying signals heading into Q2 earnings.
Name | Title | Transaction Type | Shares | Date | Note |
Hopmans, John | EVP, M&A & Strategic Finance | Tax Withholding (F) | 6,083 shares | Jul 11, 2026 | Routine tax withholding on vesting; not discretionary |
Hinson, Jeffrey T. | Director | Open Market Sale (S) | 2,115 shares | Jun 15, 2026 | Small discretionary sale; not flagged as 10b5-1; modest size relative to 47,122 shares held |
Multiple Directors (9 individuals) | Board of Directors | Stock Award (A) | 1,207–2,293 shares each | Jun 11, 2026 | Annual director compensation awards; routine; not open-market transactions |
Berchtold, Joe | President & CFO | Tax Withholding (F) | 16,603 shares | May 22, 2026 | Routine tax withholding on vesting; not discretionary; 912,451 shares held post-transaction |
Rowles, Michael | EVP & General Counsel | Tax Withholding (F) | 1,661 shares | May 22, 2026 | Routine tax withholding on vesting; not discretionary |
Berchtold, Joe | President & CFO | Tax Withholding (F) | 11,643 shares | May 13, 2026 | Routine tax withholding on vesting; not discretionary |
Rapino, Michael | President & CEO, Director | Tax Withholding (F) | 17,464 shares | May 13, 2026 | Routine tax withholding on vesting; not discretionary; 4.2M shares held post-transaction |
Hopmans, John | EVP, M&A & Strategic Finance | Option Exercise + Open Market Sale (M/S) | 83,480 exercised; 93,078 sold | May 7, 2026 | Exercise-and-sell of stock options; net sale of ~9,598 shares above exercise; routine option monetization |
Rowles, Michael | EVP & General Counsel | Option Exercise + Open Market Sale (M/S) | 63,776 exercised; 63,776 sold | May 8, 2026 | Cashless exercise-and-sell; routine option monetization; no net new shares retained |
Source: SEC Form 4 filings via Insider Transaction Data (SEC EDGAR). Open-market buys (code P) and discretionary sells (code S) only flagged for signal; tax withholding (F) and stock awards (A) are non-discretionary. No open-market buys were filed in the period.
Key Takeaway: The risk profile is asymmetric — the upside is well-telegraphed (record deferred revenue, double-digit ticket sales growth) while the downside risks are concentrated in two areas: the antitrust remedies phase (structural/long-term) and amphitheater per-cap spending (near-term/Q3 read-through).
Risk | Description | Probability | Impact | Timing |
Antitrust Remedies Phase — Ticketmaster Divestiture | State AGs continue to seek Ticketmaster divestiture in the remedies phase. While the DOJ settlement (no divestiture) is the judge’s stated ‘good framework,’ the states’ proposed remedies (submitted May 21, 2026) could include structural separation. Penalty phase expected to stretch into 2027. | Low-Medium (tail risk; judge has signaled DOJ framework preference) | Very High (existential for Ticketmaster segment if ordered) | 2027+ |
Amphitheater Per-Cap Spending Disappointment | With ~70% of amphitheater fan growth in Q3, any deterioration in on-site spending (food/beverage, premium experiences) from the early positive data points would be the most likely Q3 negative surprise. Consumer trade-down in a softer macro environment is the primary driver. | Low-Medium (early data positive; no trade-down observed as of late May) | Medium (per-cap is a key AOI driver at owned venues) | Q3 2026 (peak amphitheater season) |
Secondary Ticketing Headwind Larger Than Guided | Management guided to a mid-single-digit drag to Ticketmaster AOI from secondary market changes. If the structural step-down is larger than anticipated (e.g., broker inventory removal reduces primary demand signals), the headwind could exceed guidance. | Low (management has quantified and appears to have visibility) | Medium (Ticketmaster AOI is a key segment) | FY2026 (one-time; comps out in 2027) |
Macro Consumer Spending Slowdown | A broader consumer spending pullback (driven by tariffs, inflation, or labor market softening) could reduce discretionary spending on live events. Management has seen no evidence of this as of late May, but the risk increases if macro deteriorates through summer. | Low-Medium (no current evidence; management explicitly dismissed) | Medium-High (live events are discretionary; high-ticket shows most vulnerable) | Q3–Q4 2026 |
Venue Nation Capex Execution Risk | With $1.1–$1.2B in FY2026 capex (the highest in company history), construction delays, cost overruns, or permitting issues at new venues could delay the AOI ramp. Pre-opening costs of ~$50M are already guided. | Low-Medium (20 venues in construction or permitted; execution track record is solid) | Medium (delays push AOI ramp to 2030+) | 2026–2028 |
Tunney Act Review — DOJ Settlement Rejection | The judge’s Tunney Act review of the DOJ settlement (ruling expected Sep/Oct 2026) could reject the settlement as insufficient, reopening the structural remedy debate. The judge has publicly stated the settlement is a ‘good framework,’ reducing this risk. | Low (judge has signaled approval; DOJ settlement is the baseline) | High (rejection would reopen structural remedy debate) | Sep/Oct 2026 |